Soluble Alpha-APP (sAPPalpha) Regulates CDK5 Expression and Activity in Neurons

30Citations
Citations of this article
55Readers
Mendeley users who have this article in their library.

Abstract

A growing body of evidence suggests a role for soluble alpha-amyloid precursor protein (sAPPalpha) in pathomechanisms of Alzheimer disease (AD). This cleavage product of APP was identified to have neurotrophic properties. However, it remained enigmatic what proteins, targeted by sAPPalpha, might be involved in such neuroprotective actions. Here, we used high-resolution two-dimensional polyacrylamide gel electrophoresis to analyze proteome changes downstream of sAPPalpha in neurons. We present evidence that sAPPalpha regulates expression and activity of CDK5, a kinase that plays an important role in AD pathology. We also identified the cytoprotective chaperone ORP150 to be induced by sAPPalpha as part of this protective response. Finally, we present functional evidence that the sAPPalpha receptor SORLA is essential to mediate such molecular functions of sAPPalpha in neurons. © 2013 Hartl et al.

Cite

CITATION STYLE

APA

Hartl, D., Klatt, S., Roch, M., Konthur, Z., Klose, J., Willnow, T. E., & Rohe, M. (2013). Soluble Alpha-APP (sAPPalpha) Regulates CDK5 Expression and Activity in Neurons. PLoS ONE, 8(6). https://doi.org/10.1371/journal.pone.0065920

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free